Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact.

NCT00394680 is registered in ClinicalTrials.gov with Shaare Zedek Medical Center as lead sponsor.

NCT NCT00394680
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00394680 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stents, Drug Eluting Stents, and CABG- Financial and Clinical Impact.
Lead sponsor
Shaare Zedek Medical Center
Phase
Observational
Overall status
Completed
Start date
November 30, 2006
Completion date
May 31, 2007
Enrollment
700 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

angina unstable, coronary arteriosclerosis, myocardial infarction